NCT00115310View on ClinicalTrials.gov

Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

October 31, 2006

Conditions
Peripheral Nervous System DiseasesPainNeuralgiaHerpes ZosterShingles
Interventions
DRUG

NGX-4010

Sponsors

Lead Sponsor

NeurogesX
All Listed Sponsors
lead

NeurogesX

INDUSTRY